Systane Ultra
NDC 0065-1431, Polyethylene Glycol 400 and Propylene Glycol, solution/ drops, from Alcon Laboratories, Inc..
- Product NDC
- 0065-1431
- Status
- Listed
- Labeler
- Alcon Laboratories, Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M018
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0065-1431 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 4004 mg/mL
- PROPYLENE GLYCOL3 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0065-1431-01 | 00065143101 | 1 BOTTLE, DROPPER in 1 CARTON (0065-1431-01) / 1.5 mL in 1 BOTTLE, DROPPER |
| 0065-1431-05 | 00065143105 | 1 BOTTLE, DROPPER in 1 CARTON (0065-1431-05) / 10 mL in 1 BOTTLE, DROPPER |
| 0065-1431-18 | 00065143118 | 3 BOTTLE, DROPPER in 1 CARTON (0065-1431-18) / 10 mL in 1 BOTTLE, DROPPER |
| 0065-1431-21 | 00065143121 | 1 BOTTLE, DROPPER in 1 CARTON (0065-1431-21) / 3 mL in 1 BOTTLE, DROPPER |
| 0065-1431-28 | 00065143128 | 2 BOTTLE, DROPPER in 1 CARTON (0065-1431-28) / 4 mL in 1 BOTTLE, DROPPER |
| 0065-1431-31 | 00065143131 | 1 BOTTLE, DROPPER in 1 CARTON (0065-1431-31) / 4 mL in 1 BOTTLE, DROPPER |
| 0065-1431-41 | 00065143141 | 2 BOTTLE, DROPPER in 1 CARTON (0065-1431-41) / 10 mL in 1 BOTTLE, DROPPER |
| 0065-1431-80 | 00065143180 | 1 BOTTLE, DROPPER in 1 CARTON (0065-1431-80) / 3 mL in 1 BOTTLE, DROPPER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 00065143105
GET /v1/drugs/nadac/00065143105NADAC price for package 00065143121
GET /v1/drugs/nadac/00065143121NADAC price for package 00065143128
GET /v1/drugs/nadac/00065143128NADAC price for package 00065143141
GET /v1/drugs/nadac/00065143141
Use it
Look up 0065-1431 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0065-1431 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0065-1431. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.